Unlike other tumor suppressors, the vast majority of cancer-associated mutations in TP53 are missense mutations or gain-of-function (GOF) mutations leading to single base-pair substitutions (SNP) in the translation of a different amino acid in that position of the full-length protein. The gene discussed is TP53; the disease is cancer.